HSPBAP1

gene
On this page

Also known as FLJ22623PASS1

Summary

HSPBAP1 (HSPB1 associated protein 1, HGNC:16389) is a protein-coding gene on chromosome 3q21.1, encoding HSPB1-associated protein 1 (Q96EW2). May play a role in cellular stress response.

This gene encodes a protein that binds to one of the small heat shock proteins, specifically hsp27. Hsp27 is involved with cell growth and differentiation. This encoded protein was found to be abnormally expressed in patients with intractable epilepsy, although how brain function is affected remains unknown.

Source: NCBI Gene 79663 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 77 total
  • MANE Select transcript: NM_024610

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16389
Approved symbolHSPBAP1
NameHSPB1 associated protein 1
Location3q21.1
Locus typegene with protein product
StatusApproved
AliasesFLJ22623, PASS1
Ensembl geneENSG00000169087
Ensembl biotypeprotein_coding
OMIM608263
Entrez79663

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 10 protein_coding, 5 protein_coding_CDS_not_defined

ENST00000306103, ENST00000463266, ENST00000465044, ENST00000467643, ENST00000471534, ENST00000478601, ENST00000877414, ENST00000877415, ENST00000877416, ENST00000877417, ENST00000936099, ENST00000936100, ENST00000936101, ENST00000936102, ENST00000971052

RefSeq mRNA: 2 — MANE Select: NM_024610 NM_001320728, NM_024610

CCDS: CCDS3017

Canonical transcript exons

ENST00000306103 — 8 exons

ExonStartEnd
ENSE00001817071122793617122793831
ENSE00003513857122755260122755431
ENSE00003517108122759224122759360
ENSE00003586856122777721122777906
ENSE00003621091122741003122741113
ENSE00003632554122739999122740875
ENSE00003665516122752591122752674
ENSE00003693783122768701122768882

Expression profiles

Bgee: expression breadth ubiquitous, 275 present calls, max score 95.19.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.8769 / max 146.2397, expressed in 1666 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
441475.53271620
441461.1593596
441480.184887

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002395.19gold quality
secondary oocyteCL:000065593.13gold quality
granulocyteCL:000009490.47gold quality
bloodUBERON:000017890.33gold quality
gastrocnemiusUBERON:000138888.86gold quality
hindlimb stylopod muscleUBERON:000425288.63gold quality
monocyteCL:000057688.61gold quality
mononuclear cellCL:000084288.55gold quality
leukocyteCL:000073888.46gold quality
spleenUBERON:000210688.34gold quality
muscle of legUBERON:000138388.17gold quality
endothelial cellCL:000011587.35gold quality
mucosa of stomachUBERON:000119986.32gold quality
skeletal muscle organUBERON:001489285.36gold quality
muscle organUBERON:000163085.35gold quality
skin of abdomenUBERON:000141685.26gold quality
skin of legUBERON:000151185.08gold quality
left lobe of thyroid glandUBERON:000112084.94gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.91gold quality
right lobe of thyroid glandUBERON:000111984.76gold quality
metanephros cortexUBERON:001053384.46gold quality
thyroid glandUBERON:000204684.28gold quality
right lungUBERON:000216784.09gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.00gold quality
skin of hipUBERON:000155483.89gold quality
placentaUBERON:000198783.73gold quality
left adrenal gland cortexUBERON:003582583.59gold quality
right adrenal gland cortexUBERON:003582783.47gold quality
right adrenal glandUBERON:000123383.29gold quality
small intestine Peyer’s patchUBERON:000345483.28gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.78

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

35 targeting HSPBAP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-428299.9975.366408
HSA-MIR-548AW99.9972.573559
HSA-MIR-548N99.9871.944170
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-1255A99.7468.09744
HSA-MIR-1255B-5P99.7468.16741
HSA-MIR-312599.1468.492269
HSA-MIR-485-5P99.1064.781889
HSA-MIR-6884-5P99.1064.501987
HSA-MIR-628-3P99.0468.37814
HSA-MIR-391698.9968.042155
HSA-MIR-392698.9569.261438
HSA-MIR-5187-5P98.5467.94952
HSA-MIR-548S98.5067.171213
HSA-MIR-1212698.0964.82637
HSA-MIR-449497.8664.93850
HSA-MIR-6893-3P97.7964.911238
HSA-MIR-3928-3P97.6166.531096
HSA-MIR-370-3P97.0964.921221
HSA-MIR-514A-3P96.4367.771048

Literature-anchored findings (GeneRIF, showing 3)

  • Molecular cloning and characterization of a novel human gene (HSPBAP1) from human fetal brain (PMID:11978969)
  • HSPBAP1 is found extensively in the anterior temporal neocortex of patients with intractable epilepsy. (PMID:17568411)
  • Data suggest a novel role and a possible link for HSPBAP1 in promoting prostate cancer cell survival in androgen-deficient conditions by maintaining a basal level of androgen receptor-mediated transcription. (PMID:25359680)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriohspbap1ENSDARG00000033771
mus_musculusHspbap1ENSMUSG00000022849
rattus_norvegicusHspbap1ENSRNOG00000002241
drosophila_melanogasterHSPBAP1FBGN0263025

Paralogs (4): KDM8 (ENSG00000155666), TYW5 (ENSG00000162971), HIF1AN (ENSG00000166135), JMJD7 (ENSG00000243789)

Protein

Protein identifiers

HSPB1-associated protein 1Q96EW2 (reviewed: Q96EW2)

Alternative names: 27 kDa heat shock protein-associated protein 1, Protein associated with small stress protein 1

All UniProt accessions (1): Q96EW2

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in cellular stress response.

Subunit / interactions. Interacts with CRYAB and HSPB1.

Subcellular location. Cytoplasm.

Tissue specificity. Widely expressed.

Disease relevance. A chromosomal aberration involving HSPBAP1 has been found in a family with renal carcinoma. Translocation t(2;3)(q35;q21) with the putative pseudogene DIRC3. Produces a hybrid mRNA encoding a truncated HSPBAP1 lacking the first 36 amino acids.

Isoforms (3)

UniProt IDNamesCanonical?
Q96EW2-11yes
Q96EW2-22
Q96EW2-33

RefSeq proteins (2): NP_001307657, NP_078886* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003347JmjC_domDomain
IPR013296HSPB1-associated_protein_1Family
IPR041667Cupin_8Domain

Pfam: PF13621

UniProt features (13 total): splice variant 4, sequence conflict 3, region of interest 2, chain 1, domain 1, compositionally biased region 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96EW2-F179.790.64

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 131 (showing top): GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, USF_C, MYCMAX_01, BLALOCK_ALZHEIMERS_DISEASE_UP, USF_01, LIAO_METASTASIS, LIAO_HAVE_SOX4_BINDING_SITES, chr3q21, MARSON_BOUND_BY_FOXP3_STIMULATED, SANSOM_APC_TARGETS, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_DIOXYGENASE_ACTIVITY

GO Biological Process (0):

GO Molecular Function (2): 2-oxoglutarate-dependent dioxygenase activity (GO:0016706), protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen1
dioxygenase activity1
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

618 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HSPBAP1HSPB2Q16082882
HSPBAP1HSPB1P04792873
HSPBAP1HSPB3Q12988856
HSPBAP1SLC49A4Q96SL1732
HSPBAP1JMJD4Q9H9V9707
HSPBAP1RIOX1Q9H6W3681
HSPBAP1DIRC1Q969H9638
HSPBAP1LRIG1Q96JA1588
HSPBAP1RIOX2Q8IUF8560
HSPBAP1PPP1R36Q96LQ0503
HSPBAP1C9K0I3C9K0I3502
HSPBAP1JMJD6Q6NYC1501
HSPBAP1PTPRGP23470494
HSPBAP1RNF139Q8WU17490
HSPBAP1RBM46Q8TBY0470

IntAct

29 interactions, top by confidence:

ABTypeScore
HSPBAP1ARHGEF5psi-mi:“MI:0915”(physical association)0.720
ARHGEF5HSPBAP1psi-mi:“MI:0915”(physical association)0.720
XAF1AKT1psi-mi:“MI:0914”(association)0.670
HSPBAP1NCALDpsi-mi:“MI:0915”(physical association)0.590
NUTM1HSPBAP1psi-mi:“MI:0915”(physical association)0.560
HSPBAP1NUTM1psi-mi:“MI:0915”(physical association)0.560
MAGEA1MAGEB3psi-mi:“MI:0914”(association)0.530
SDE2HSPBAP1psi-mi:“MI:0915”(physical association)0.500
HSPBAP1ABHD10psi-mi:“MI:0915”(physical association)0.500
HSPB1HSPBAP1psi-mi:“MI:0915”(physical association)0.400
HSPBAP1TK1psi-mi:“MI:0915”(physical association)0.370
MAGEA1ANKHD1psi-mi:“MI:0914”(association)0.350
FOXD4L6ANKRD28psi-mi:“MI:0914”(association)0.350
HSPBAP1SERPINC1psi-mi:“MI:0914”(association)0.350
KRR1LGALS7psi-mi:“MI:0914”(association)0.350
SDE2HOXB6psi-mi:“MI:0914”(association)0.350
ABHD10VWA8psi-mi:“MI:0914”(association)0.350
IMPDH1MGST3psi-mi:“MI:0914”(association)0.350
MAGEA1ANKRD17psi-mi:“MI:0914”(association)0.350
ARHGEF5HSPBAP1psi-mi:“MI:0915”(physical association)0.000
HSPBAP1PTNpsi-mi:“MI:0915”(physical association)0.000

BioGRID (27): HSPBAP1 (Two-hybrid), NUTM1 (Two-hybrid), HSPBAP1 (Affinity Capture-MS), HSPBAP1 (Affinity Capture-MS), HSPBAP1 (Affinity Capture-MS), HSPBAP1 (Affinity Capture-MS), NCALD (Affinity Capture-MS), HSPBAP1 (Affinity Capture-MS), HSPBAP1 (Reconstituted Complex), PTN (Two-hybrid), HSPBAP1 (Two-hybrid), HSPBAP1 (Affinity Capture-MS), HOXA5 (Affinity Capture-MS), HSPBAP1 (Affinity Capture-MS), RPS29 (Affinity Capture-MS)

ESM2 similar proteins: A1L3L1, A2RT67, A3KPW7, A4IIA7, A8C750, A8C752, D2HNY3, E1BGQ2, E1C3P4, Q08CL8, Q08DZ8, Q0IHB3, Q149N8, Q1RMU2, Q1RMZ1, Q3MJ13, Q3T1H6, Q5F3F2, Q5RED8, Q5VVJ2, Q5ZJ87, Q66J91, Q69Z66, Q6AYF5, Q6DE97, Q6GR37, Q6P1E7, Q6PNC0, Q6YHU6, Q7TPQ3, Q8BKW4, Q8BXK4, Q8IWR0, Q8IYF3, Q8IZE3, Q8K2I9, Q8NA31, Q8NEN0, Q8NFZ0, Q96EW2

Diamond homologs: A2RSX7, A2RUC4, A8E534, B5XF11, E1C7T6, F4K2M8, Q08BV2, Q2U6D4, Q4IER0, Q4WVD1, Q54LV7, Q58CU3, Q5BH52, Q67ZB6, Q6C3P4, Q96EW2, Q9P3K9, Q5UQY3, Q6AXL5, Q8BK58, B2GUS6, P59723, Q0WVR4, Q1JP61, Q497B8, Q54FG7, Q55DF5, Q5BKC6, Q8BLR9, Q8N371, Q9CXT6, Q9NWT6, O94606, Q3TA59, Q6AY40, Q8RWR1, Q9W0M3, Q9H9V9, Q54FM1, Q96S16

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance56
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1678 predictions. Top by Δscore:

VariantEffectΔscore
3:122740872:CAAC:Cacceptor_gain1.0000
3:122740875:CCTAA:Cacceptor_loss1.0000
3:122740876:CTAA:Cacceptor_loss1.0000
3:122740877:T:Cacceptor_loss1.0000
3:122740999:CTAC:Cdonor_loss1.0000
3:122741000:TACC:Tdonor_loss1.0000
3:122741001:ACC:Adonor_loss1.0000
3:122741002:C:Adonor_loss1.0000
3:122768696:CTTA:Cdonor_loss1.0000
3:122768697:TTAC:Tdonor_loss1.0000
3:122768699:ACCTG:Adonor_loss1.0000
3:122768700:C:CAdonor_loss1.0000
3:122768883:C:CCacceptor_gain1.0000
3:122777757:T:Cdonor_gain1.0000
3:122777906:CCTAG:Cacceptor_loss1.0000
3:122777907:C:CCacceptor_gain1.0000
3:122777907:CTA:Cacceptor_loss1.0000
3:122777908:T:Cacceptor_loss1.0000
3:122740876:C:CCacceptor_gain0.9900
3:122741110:CTTC:Cacceptor_gain0.9900
3:122741114:C:CCacceptor_gain0.9900
3:122741115:T:Aacceptor_loss0.9900
3:122755432:C:CCacceptor_gain0.9900
3:122755436:T:TCacceptor_gain0.9900
3:122759226:T:Adonor_gain0.9900
3:122768879:GGAA:Gacceptor_gain0.9900
3:122768880:GAA:Gacceptor_gain0.9900
3:122768880:GAAC:Gacceptor_loss0.9900
3:122768881:AA:Aacceptor_gain0.9900
3:122768883:CT:Cacceptor_loss0.9900

AlphaMissense

3246 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:122752602:A:GW272R0.999
3:122752602:A:TW272R0.999
3:122755424:A:GW193R0.999
3:122755424:A:TW193R0.999
3:122759303:A:GW164R0.999
3:122759303:A:TW164R0.999
3:122759351:A:GW148R0.999
3:122759351:A:TW148R0.999
3:122752612:A:CS268R0.998
3:122752612:A:TS268R0.998
3:122752614:T:GS268R0.998
3:122752664:A:TV251D0.998
3:122755347:A:CS218R0.998
3:122755347:A:TS218R0.998
3:122755349:T:GS218R0.998
3:122759270:G:CH175D0.998
3:122752600:C:AW272C0.997
3:122752600:C:GW272C0.997
3:122752647:G:CH257D0.997
3:122752650:A:GW256R0.997
3:122752650:A:TW256R0.997
3:122755356:A:CS215R0.997
3:122755356:A:TS215R0.997
3:122755358:T:GS215R0.997
3:122755428:T:AK191N0.997
3:122755428:T:GK191N0.997
3:122752606:G:CN270K0.996
3:122752606:G:TN270K0.996
3:122755350:G:CF217L0.996
3:122755350:G:TF217L0.996

dbSNP variants (sampled 300 via entrez): RS1000027824 (3:122743820 G>A), RS1000115234 (3:122768440 C>A), RS1000121196 (3:122763876 C>T), RS1000272972 (3:122787266 G>A), RS1000299953 (3:122753992 G>C), RS1000415567 (3:122753596 T>C), RS1000578592 (3:122766241 T>A), RS1000621934 (3:122747999 A>T), RS1000733263 (3:122747909 T>C,G), RS1000756700 (3:122755574 T>C), RS1000835496 (3:122782278 A>C,T), RS1000888401 (3:122771680 C>G), RS1000901829 (3:122751613 T>C), RS1001048348 (3:122789460 C>T), RS1001070846 (3:122758279 C>T)

Disease associations

OMIM: gene MIM:608263 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

42 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporineincreases expression4
Valproic Acidaffects expression, decreases expression, increases expression3
bisphenol Aaffects methylation2
sodium arseniteaffects cotreatment, decreases expression, increases abundance, increases expression2
aminomethylphosphonic acid (AMPA)increases expression1
triphenyl phosphateaffects expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
cypermethrinincreases expression1
manganese chlorideincreases abundance, affects cotreatment, decreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
pentabromodiphenyl etherincreases expression1
perfluoro-n-nonanoic acidincreases expression1
abrineincreases expression1
2,2’,4,4’-tetrabromodiphenyl etherincreases expression1
NSC 689534affects binding, increases expression1
2,3,5-trichloro-6-phenyl-(1,4)benzoquinonedecreases expression1
Resveratrolaffects cotreatment, increases expression1
Decitabineaffects expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Glyphosateincreases expression1
Air Pollutantsaffects expression, increases abundance1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Atrazinedecreases expression1
Benzo(a)pyreneincreases expression1
Cisplatinaffects expression1
Copperaffects binding, increases expression1
Doxorubicindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.